文献速递神经MRPET

TERT启动子突变与组织学分级在IDH野生型低级别胶质瘤中的影像评估

Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: The value of perfusion-weighted image, diffusion-weighted image, and 18F-FDG-PET.
PubMed 文献 · Eur J Radiol · 2022-12-19

本研究回顾性纳入59例病理确诊IDH野生型组织学低级别星形细胞瘤患者,比较TERT启动子突变型与野生型及组织学II级与III级之间的灌注、弥散和FDG-PET影像标志物。结果显示常规影像、FDG-PET T/N比、nrCBV及ADC直方图参数均无法预测TERTp突变,但III级肿瘤nrCBV值和T/N比显著高于II级、ADC参数显著低于II级。

要点

  • IDH野生型低级别星形细胞瘤中,常规MRI及FDG-PET半定量参数不能预测TERT启动子突变。
  • nrCBV值、FDG-PET T/N比和ADC参数有助于区分组织学II级与III级。
  • 阅片时对IDH野生型低级别星形细胞瘤应关注灌注和弥散参数以辅助分级。

关键影像表现/征象

  • TERTp突变型与野生型肿瘤在常规影像表现上无显著差异。
  • TERTp突变型与野生型肿瘤的FDG-PET T/N比、nrCBV及ADC直方图参数均无显著差异。
  • 组织学III级IDH野生型星形细胞瘤的nrCBV值和T/N比显著高于II级。
  • 组织学III级IDH野生型星形细胞瘤的ADC参数显著低于II级。

诊断标准与关键数值

  • 以p值<0.05为差异有统计学意义。
  • TERTp突变预测:FDG-PET T/N比、nrCBV及ADC直方图参数在突变型与野生型间均无显著差异。
  • 组织学分级预测:III级肿瘤nrCBV值和T/N比显著高于II级,ADC参数显著低于II级。

临床应用与阅片要点

  • 对IDH野生型组织学低级别星形细胞瘤,可结合nrCBV、FDG-PET T/N比和ADC参数辅助判断组织学分级。
  • 不宜依据常规MRI、FDG-PET或灌注/弥散参数推断TERT启动子突变状态。

局限性

  • 单中心回顾性研究,样本量59例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The telomerase reverse transcriptase promoter (TERTp) mutation is an unfavorable prognostic factor in isocitrate dehydrogenase-wildtype (IDHwt) histologically lower-grade astrocytoma (LGA), which was incorporated as a key component in the WHO 2021 classification of IDHwt LGA, replacing histologic grades in the WHO 2016 classification. The purpose of this study was to identify the imaging characteristics predictive of TERTp mutations in IDHwt LGA.

METHODS: This retrospective study was approved by our institutional review board. This single-center study retrospectively included 59 patients with pathologically confirmed IDHwt LGA with known TERTp mutation status. In addition to clinical information and morphological characteristics, semi-quantitative imaging biomarkers such as the tumor-to-normal ratio (T/N ratio) on 18F-FDG-PET, normalized apparent diffusion coefficient (nADC), and histogram parameters from normalized relative cerebral blood volume (nrCBV) maps were compared between (a) TERTp-wildtype and TERTp-mutant tumors or (b) grade II and grade III astrocytoma. A p value < 0.05 was considered significant.

RESULTS: There were no significant differences in the conventional imaging findings, T/N ratio on FDG-PET, nrCBV or ADC histogram metrics between IDHwt LGA with TERTp mutations and those without. Grade III IDHwt astrocytomas exhibited significantly higher nrCBV values, T/N ratio and lower ADC parameters than grade II IDHwt astrocytoma.

CONCLUSIONS: In patients with IDHwt LGA, T/N ratio, nrCBV values and nADC may be surrogate markers for predicting histologic grade, but are not useful for predicting TERTp mutations.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ikeda, Sakata, Fushimi, et al. Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: The value of perfusion-weighted image, diffusion-weighted image, and 18F-FDG-PET. Eur J Radiol. 2022. PMID: 36571926. doi:10.1016/j.ejrad.2022.110658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。